Carnitine palmitoyl transferase II deficiency, neonatal form

Get in touch with RARE Concierge.

Contact RARE Concierge

Synonyms: CPT2, lethal systemic form | CPT2, neonatal form | CPTII, lethal systemic form | CPTII, neonatal form | Carnitine palmitoyl transferase II deficiency, lethal systemic form | Carnitine palmitoyl transferase deficiency type 2, lethal systemic form | Carnitine palmitoyl transferase deficiency type 2, neonatal form

The neonatal form of carnitine palmitoyltransferase II (CPT II) deficiency (see this term) an inherited disorder that affects mitochondrial oxidation of long chain fatty acids (LCFA) is the lethal form of the disease which presents with multisystem failure.

Data from Orphanet are used to provide information on a disease's name, synonym(s), and overview. Reference: Access aggregated data from Orphanet at Orphadata. Orphadata: Free access data from Orphanet. © INSERM 1999. Available on http://www.orphadata.org. Data version June 2024

Newly diagnosed with
Carnitine palmitoyl transferase II deficiency, neonatal form?

Our RARE Concierge Services Guides are available to assist you by providing information, resources and connections as you navigate your rare disease journey.

Get Concierge Help

Advocacy Organizations

Association Aux Pas du Coeur – Côte d’ivoire

Our organization wants to raise awareness and recognition of rare diseases in Ivory Coast. Our mission is to: Raise awareness and campaign to help with the diagnosis and free therapeutic care of patients. Request and/or contribute to actions relating to the training of the medical profession to be able to make a final diagnosis and ensure continuous monitoring of patients easily.

Mississippi Metabolics Foundation

Our mission at Mississippi Metabolics Foundation (MMF) is to advocate, educate, and support families in MS affected by genetic metabolic disorders/inborn errors of metabolism (IEM's). MMF promotes initiatives and further advancements in legislation, education, research, clinical trials, studies, therapies, targeted treatments, and eventual cures for IEM’s and all rare diseases.

MitoAction

MitoAction’s mission is to improve the quality of life for children, adults, and families living with mitochondrial disease through support, education, outreach, advocacy, clinical research initiatives and by granting wishes for children affected by mitochondrial disease.

Don't see your organization here. Let us know here.

Clinical Trials

For a list of clinical trials in this disease area, please click here.